EB070
/ Biotech Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 22, 2026
A Phase Ib clinical study evaluating the multiple-dose escalation of EB070 injection in adult patients with moderate to severe asthma.
(chinadrugtrials.org.cn)
- P1 | N=20 | Not yet recruiting | Sponsor: Beijing Dongfang Baitai Biotechnology Co., Ltd. / Beijing Jingyi Taixiang Technology Development Co., Ltd.
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases • IL13 • IL5
October 22, 2026
A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study of Multiple Ascending Doses of EB070 Injection in Adults With Moderate-to-Severe Asthma
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Biotech Pharmaceutical Co., Ltd.
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1